Table 3 Baseline characteristics in women in SOF lead ancillary study by survival/mortality status.

Age (years), mean ± SD

72 ± 5

70 ± 4

0.001

Education (years), mean ± SD

12 ± 3

12 ± 3

0.811

Body mass index(kg/m²⁾), mean ± SD

26 ± 5

27 ± 5

0.164

Alcohol (drinks/wk), mean ± SD

1.9 ± 5

1.8 ± 4

0.840

Current smoker, n (%)

25 (20)

41(10)

0.002

Hypertension, n (%)

47 (39)

106 (26)

0.007

Diabetes, n (%)

15 (12)

40 (10)

0.435

Current estrogen use, n (%)

12 (10)

55 (13)

0.283

Walk for exercise (yes/no), n (%)

41 (33)

172 (42)

0.087

Total hip, bone density (g/cm²), mean ± SD

0.71 ± 0.13

0.77 ± 0.13

< 0.001

All cause death, B-Pb (μg/dL) [μmol/L], mean ± SD

5.56 ± 3 [0.27 ± 0.14]

5.17 ± 2 [0.25 ± 0.1]

0.093

CVD death, B-Pb (μg/dL), [μmol/L], mean ± SD

5.81 ± 3 [0.28 ± 0.14 ]

5.19 ± 3 [0.25 ± 0.14]

0.059

CHD death, B-Pb (μg/dL), [μmol/L], mean ± SD

5.61 ± 2 [0.27 ± 0.1]

5.19 ± 2 [0.25 ± 0.1]

0.373

Stroke death, B-Pb (μg/dL), [μmol/L], mean ± SD

6.33 ± 3 [0.30 ± 0.14]

5.21 ± 2 [0.25 ± 0.1]

0.028

Cancer death, B-Pb (μg/dL), [μmol/L], mean ± SD

5.34 ± 2 [0.26 ± 0.1]

5.25 ± 2 [0.25 ± 0.1]

0.812

Other death, B-Pb (μg/dL), [μmol/L], mean ± SD

5.39 ± 4 [0.26 ± 0.19]

5.25 ± 2 [0.25 ± 0.1]

0.745